Z-2192-2013 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-2192-2013 was initiated by Becton Dickinson & Company on Jul 10, 2013 and is designated Class II. Reason for recall: The Lancet will not retract after activation thus creating a potential for exposure to a used sharp. The recall status is terminated (terminated Mar 19, 2014). Affected quantity: US - 39,800 units ; Canada - 18,400 units.

Recall details

Product Type
Devices
Report Date
Sep 18, 2013
Initiation Date
Jul 10, 2013
Termination Date
Mar 19, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
US - 39,800 units ; Canada - 18,400 units

Product description

BD Microtainer Quikheel Lancet 1.0 mm incision Depth 2.5 mm Incision Length REF 368101 Rx Only Becton, Dickinson and Company, Franklin Lakes, NJ 07417 USA Made in USA. Used to perform heel sticks for the purpose of collecting skin puncture blood.

Reason for recall

The Lancet will not retract after activation thus creating a potential for exposure to a used sharp.

Distribution pattern

Distributed in the states of CT, KY, IL, NY, PA, TX, and VA and the country of Canada.

Code information

REF # 368101 Lot #3116007 Class I Exempt Device listing Number E158602

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2192-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2192-2013. Report a data issue: hello@regdatalab.com.